Khartis Therapeutics
Latest round
- Series B
Last raised
- Aug 2026
Total raised
- $50M
Investors
- 6
About Khartis Therapeutics
Based in the US, Founded in 2024 by Robert Hoffman (CEO and Head of Drug Discovery) Craig Murphy (CSO), and Chris LeMasters (Executive Chairman) in San Diego, California, US. Khartis Therapeutics, Inc. operates as a biotechnology company that provides oral drug therapies for immune-mediated and chronic diseases.
Who invested in Khartis Therapeutics
6 investors across 1 round
See all investors in Khartis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 13, 2026
Amount
$50M
Investors
Questions about Khartis Therapeutics
Who invested in Khartis Therapeutics?
Khartis Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Khartis Therapeutics raised?
Khartis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Khartis Therapeutics last raise money?
Khartis Therapeutics's most recent round on record is a Series B, in Aug 2026.
What does Khartis Therapeutics do?
Based in the US, Founded in 2024 by Robert Hoffman (CEO and Head of Drug Discovery) Craig Murphy (CSO), and Chris LeMasters (Executive Chairman) in San Diego, California, US.
Where is Khartis Therapeutics headquartered?
Khartis Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Khartis Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Khartis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Khartis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.